



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

3989






                                    ANSWERED ON: 
                                

19.03.2021






COVID Vaccines in the Pipeline




Balashowry Vallabbhaneni













                                                    Margani Bharat
                                                












                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:(a) the details of Covid vaccines that are in the pipeline and are in phase I, II and III trials;(b) the time by which the above vaccines are likely to enter into market;(c) whether it is also true that Bharat Biotech is also developing intranasal Covid vaccine; and(d) if so, the details thereof?






ANSWER




                                                        ANSWERTHE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(SHRI ASHWINI KUMAR CHOUBEY)(a) & (b): Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health & Family Welfare has granted permission to conduct clinical trials of COVID-19 vaccines to various Manufacturers/Importers in the country. The details along with trials, stage-wise are as under: Phase I clinical trial:1.	M/s Bharat Biotech International Limited, Hyderabad for Intranasal   Adenoviral   vector   COVID-19 vaccine   (BBV154).  Phase I/II clinical trial:2.	M/s Bharat Biotech International Limited, Hyderabad for Inactivated Corona Virus Vaccine (Intradermal Route)3.	M/s Biological E Limited, Hyderabad for Receptor Binding Domain of SARS-CoV-24.	M/s Gennova Biopharmaceuticals Limited, Pune for mRNA Vaccine for Injection (COVID-19)Phase II/ III clinical trial:5.	M/s Dr. Reddy’s Laboratories Limited, Hyderabad for Gam-COVID-Vac combined vector vaccine 6.	M/s Serum Institute of India Pvt. Ltd., Pune for COVOVAX [SARS-CoV-2 recombinant spike protein nanoparticle vaccine.Phase III clinical trial:7.	M/s Cadila Healthcare Ltd., Ahmedabad for DNA based Corona Virus VaccineFurther, 14 COVID-19 vaccines of various technology platforms are under preclinical development stage in the country.        	The approval of COVID-19 vaccine for manufacturing/marketing is based on the submission of adequate data including Chemistry, Manufacturing and Control (CMC), non-clinical (animal studies) data, clinical trial data as per provisions of New Drugs and Clinical Trials (ND & CT) Rules, 2019 and outcomes of evaluation of the same in consultation with Subject Expert Committee (SEC). The detailed guidelines and requirements for approval of clinical trial or New Drugs are specified in Second Schedule of the ND & CT Rules, 2019.(c) & (d): CDSCO in consultation with Subject Expert Committee (SEC), has granted permission on 12.02.2021 to M/s Bharat Biotech International Limited for conduct of Phase-I clinical trial of Chimpanzee Adenovirus Vectored COVID-19 Vaccine (BBV154) for Intranasal route of administration.
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113210309







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







